The Prohost Effect of Antimicrobial Agents as a Predictor of Clinical Outcome

REFERENCES

• Labro MT. Host Defense and Infection. New York, Marcel Dekker, Inc. 1994: 1-68.
   Google Scholar
• Ritts RE. Antibiotics as biological response modifiers. J Antimicrob Chemother 1991; 26 (suppl. C): 31-6.
   Google Scholar
• Labro MT. Immunomodulation by antibacterial agents. Is it clinically relevant? Drugs 1993; 45: 319-28.
   PubMed Web of Science ®Google Scholar
• Gemmell CG. Antibiotics and neutrophil function-potential immunomodulating activities, J Antimicrob Chemother 1993; 31 (suppl. B): 23-33.
   PubMedGoogle Scholar
• Labro MT. Interactions between antimicrobial drugs and phagocytes: an overview. Int J Antimicrob Agents 1993; 3: 73-87.
   PubMedGoogle Scholar
• Labro MT. Effect of antimicrobial agents on polymorphonuclear neutrophil functions. In: Raoult D. ed. Antimicrobial. Agents and Intracellular Pathogens. Boca Raton, Ann Arbor, London, Tokyo CRC Press 1993: 87-135.
   Google Scholar
• Barrett JF. The immunomodulatory activities of antibacterials. Exp Opin Invest Drugs 1995; 4: 551-7.
   Google Scholar
• Labro MT. Immunomodulatory actions of antibacterial agents. Clin Immunother 1996; 6: 454-464.
   Google Scholar
• Kawana M, Kawana C, Giebink GS. Penicillin-treatment accelerates middle ear inflammation in experimental pneumococcal otitis media. Infect Immun 1992; 60: 1908-12.
   PubMed Web of Science ®Google Scholar
• McConnell JS, Cohen J. Release of endotoxin from Escherichia coli by quinolones. J Antimicrob Chemother 1986; 18: 765-6.
   PubMed Web of Science ®Google Scholar
• Prins JM, Van Deventer SJH, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-8.
   PubMed Web of Science ®Google Scholar
• Prins JM, Kuijper EJ, Mevissen MLCM, Speelman P, Van Deventer SJH. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun 1995; 63: 2236-42.
   PubMed Web of Science ®Google Scholar
• Yokoshi T, Kusumi A, Kido N et al. Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide. Antimicrob Agents Chemother 1996; 40: 2410-2.
   PubMed Web of Science ®Google Scholar
• Gemmell CG. Antibiotics and the expression of staphylococcal virulence. J Antimicrob Chemother 1995; 36: 283-91.
   PubMed Web of Science ®Google Scholar
• Hirakata Y, Kaku M, Mizukane R et al. Potential effects of erythromycin on host defence systems and virulence of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36: 1922-7.
   PubMed Web of Science ®Google Scholar
• Tateda K, Ishii Y, Matsumoto T et al. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin and azithromycin. Antimicrob Agents Chemother 1996; 40: 2271-5.
   PubMed Web of Science ®Google Scholar
• Kobayashi II. Airway biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. J Infect Chemother 1995; 1: 1-15.
   Google Scholar
• Silverstein SC, Kabbash C. Penetration, retention, intracellular localization and antimicrobial activity of antibiotics within phagocytes. Curr Op Hematol 1994; 1: 85-91.
   PubMedGoogle Scholar
• Labro MT. Intraphagocytic penetration of macrolide antibiotics. In: Bryskier A, Butzler JP, Neu HC, Tulkens PM (eds). Macrolides: Chemistry, Pharmacology and Clinical Uses. Paris, Arnette-Blackwell 1993: 379-88.
   Google Scholar
• Labro MT. Intracellular bioactivity of macrolides. Clin Microb Infect 1996; 1 (suppl. 1): S24-S30.
   Google Scholar
• Agouridas C, Benedetti Y, Denis A, Le Martret O, Chantot JF. Ketolides: a new distinct class of macrolide antibacterials. Synthesis and structural characteristics of RU 004. Program and Abstracts of the 35th Intersci Conf Antimicrob Agents Chemother 1995, Abstr. F-157.
   Google Scholar
• Labro MT, Abdelghaffar H, Bryskier A. Characteristics of the cellular accumulation of RU 004 by human neutrophils (PMN). Comparison with azithromycin and roxithromycin. Program and Abstracts of the 36th Intersci Conf Antimicrob Agents Chemother 1996, Abstr. F-224.
   Google Scholar
• Fassbender M, Lode H, Schiller C et al. Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva. Clin Microbiol Infect 1996; 1: 235-43.
   PubMedGoogle Scholar
• Bouvier d'Yvoire MJY, Tulkens PM. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. Program and Abstracts of the 7th Int Congr Infect Dis 1996, Abstr. 11480.
   Google Scholar
• Schentag Y. Tissue-directed pharmacokinetics. Am J Med 1991; 91 (suppl. 3A): 5S-18S.
   PubMed Web of Science ®Google Scholar
• Fontan PA, Buzzola FR, Spinedi EG, Sordelli DO. Haemophilus influenzae typeb exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. Chemotherapy 1996; 42: 71-7.
   PubMed Web of Science ®Google Scholar
• Labro MT. Effects of macrolides on host natural defenses, hr. Bryskier A, Butzler JP, Neu HC, Tulkens PM (eds). Macrolides: Chemistry, Pharmacology and Clinical Uses. Paris, Arnette-Blackwell 1993: 389-408.
   Google Scholar
• Labro MT. Eflects of macrolides on leukocytes and inflammation. In: Zinner S, Young Y, Acar J (eds). Expanding indications for the new macrolides, azalides and streptogramins. New York: Marcel Dekker 1996: 101-16.
   Google Scholar
• Fujii T, Kadota JI, Morikawa T et al. Inhibitory effect of erythromycin on interleukin-8 production by la, 25-dihy-droxyvitamin D3-stimulated THPl-cells. Antimicrob Agents Chemother 1996; 40: 1548-51.
   PubMed Web of Science ®Google Scholar
• Oishi K, Sonoda F, Kobayashi S et al. Role of interleukin-8 (1L-8) and an inhibitory effect of erythromycin on 1L-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-52.
   PubMed Web of Science ®Google Scholar
• Sakito O, Kadota JI, Kohno S, Abe K, Shirai R, Flara K. Interleukin-Iß, tumor necrosis factor alpha, and interleukin 8 in broncboalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996; 63: 42-8
   PubMed Web of Science ®Google Scholar
• Wtnish C, Parschalk B, Zedtwitz-Liebenstein K, Weihs A, El Menyawi I, Graninger W. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear function assessed ex vivo by flow cytometry. Antimicrob Agents Chemother 1996; 40: 2939-42.
   Web of Science ®Google Scholar
• Labro MT. Resistance to and immunomodulation effects of cephalosporin antibiotics. Clin Drug Invest 1995; 9 (suppl. 3): 31-44.
   Google Scholar
• Lapenna D, Cellini L, De Gioia S et al. Cephalosporins are scavengers of hypochlorous acid. Biochem Pharmacol 1995; 49: 1249-54.
   PubMed Web of Science ®Google Scholar
• Labro MT. Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vivo immunomodulatory properties. J Antimicrob Chemother 1990; 26 (suppl. C): 37-47.
   PubMedGoogle Scholar
• Meloni F, Ballabio P, Bianchi L, Grassi FA, Gialdroni-Grassi G. Cefodizime modulates in vitro tumor necrosis factor alpha, interleukin-6 and interleukin-8 release from human peripheral monocytes. Chemotherapy 1995; 41: 289-95.
   PubMed Web of Science ®Google Scholar
• Pacheco Y, Hosni R, Dagrosa EE et al. Antibiotics and production of granulocyte-macrophage colony stimulating factor by human bronchial epthelial cells in vitro. Arzneim Forsch 1994; 44: 559-63.
   PubMed Web of Science ®Google Scholar
• Shin WS, Min CK, Kim YR, Yoo JH, Kang MW. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-macrophage progenitors. J Antimicrob Chemother 1996; 37: 93-103.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Parschalk B, Hasenhünd M, Wiesinger E, Graninger W. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 1995; 39: 672-6.
   PubMed Web of Science ®Google Scholar
• Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A, Stabholz A. Protection against endotoxic shock and lipopolysacchariade-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 1996; 64: 825-8.
   PubMed Web of Science ®Google Scholar
• Morikawa K, Watabe H, Araake M, Morikawa S. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996; 40: 1366-70.
   PubMed Web of Science ®Google Scholar
• Neftel KA, Hauser SP, Müller MR. Inhibition of granulopoiesis in vivo and in vitro by ß-lactam antibiotics. J Infect Dis 1985; 152: 90-8.
   PubMed Web of Science ®Google Scholar
• Tantawichien T, Tungsanga K, Swasdikul D. Reversible severe neutropenia after ceftriaxone. Scand J Infect Dis 1994; 26: 109-10.
   PubMed Web of Science ®Google Scholar
• Charak BS, Brown EG, Mazumder A. Role of granulocyte colony-stimulating factor in preventing ceftazidime-induced myelosuppression in vitro. Bone Marrow Transplant 1995; 15: 749-55.
   PubMed Web of Science ®Google Scholar
• Hahn T, Barak Y, Liebovich E, Malach L, Dagan O, Rubinstein E. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol 1991; 19: 157-60.
   PubMed Web of Science ®Google Scholar
• Kletter Y, Singer A, Nagher A, Slavin S, Fabian I. Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally-irradiated, bone-marrow-trans-planted mice. Exp Flematol 1994; 22: 360-5.
   PubMed Web of Science ®Google Scholar
• Patchen ML, Brook I, Elliott TB, Jackson WE. Adverse effects of pefloxacin in irradiated C3H/He N mice: correction with glucan therapy. Antimicrob Agents Chemother 1993; 37: 1882-5.
   PubMed Web of Science ®Google Scholar
• Moulder JW. Comparative biology of intracellular parasitism. Microbiol Rev 1995; 49: 298-337.
   Google Scholar
• Bakker-Woudenberg IAJM. Delivery of antimicrobials to infected tissue macrophages. Adv Drug Delivery Rev 1995; 17: 5-20.
   Web of Science ®Google Scholar
• Couvreur P, Fattal E, Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharmaceut Res 1991; 8: 1079-86.
   PubMed Web of Science ®Google Scholar